
PAVMW
Healthcare · Medical Devices · $769,747 market cap
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Analyst estimates aren’t available for this symbol.
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Aug 14, 2020 | Time not confirmed | -0.10 | -0.13 | -30.0% |
| Apr 9, 2020 | Time not confirmed | -0.11 | -0.19 | -72.7% |
| Nov 19, 2019 | Time not confirmed | -0.10 | -0.10 | 0.0% |
| Aug 14, 2019 | Time not confirmed | -0.13 | -0.13 | 0.0% |
| Apr 1, 2019 | Time not confirmed | -0.14 | -0.15 | -7.1% |
| Nov 14, 2018 | Time not confirmed | -0.12 | -0.12 | 0.0% |
| Aug 13, 2018 | Time not confirmed | -0.11 | -0.27 | -145.5% |
PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE). Its product pipeline also comprises EsoGuard, a molecular diagnostic esophageal DNA test; EsoCure, an…